Biogen Idec

What the Heck Happened (Again) to Biotech?
Barron's
Fri, 03/21/14 - 11:55 am
biotech
Gilead Sciences
Biogen Idec
They're no Coca-Cola, but top biopharma brands Pfizer, Biogen and Merck still worth billions
Fierce Pharma Marketing
Fri, 03/21/14 - 10:44 am
Pfizer
Biogen Idec
Merck
Pharmacyclics Drug Imbruvica Beats Rivals: Nomura
Investors.com
Thu, 03/20/14 - 05:26 pm
Imbruvica
Pharmacyclics
Gilead Sciences
Biogen Idec
chronic lymphocytic leukemia
Biogen to be added to S&P100
Yahoo/Zacks.com
Tue, 03/18/14 - 01:38 pm
Biogen Idec
FDA delays decision on Biogen's multiple sclerosis drug
Yahoo/Reuters
Tue, 03/18/14 - 08:58 am
FDA
Plegridy
Biogen Idec
MS
multiple sclerosis
Can Biogen Catch up to Merck in Alzheimer's Race?
Motley Fool
Wed, 03/12/14 - 02:58 pm
Biogen Idec
Merck
Alzheimer's disease
E2609
bapineuzumab
LY2886721
Eli Lilly
Tecfidera
With Solvadi in the mix, the FDA's class of 2013 is set for chart-busting sales
Fierce Pharma
Tue, 03/11/14 - 12:00 pm
Sovaldi
FDA
Gilead Sciences
Novo Nordisk
AbbVie
Biogen Idec
Catalysts That Could Push Top Biotech Stocks Even Higher
Wall St 24/7
Tue, 03/11/14 - 10:04 am
biotech
Biogen Idec
Gilead Sciences
Illumina
United Therapeutics
Vertex Pharmaceuticals
Biogen Idec: More Pipeline Success, More Upside
Barron's
Thu, 03/6/14 - 10:30 am
Biogen Idec
Eloctate
ISIS-SMNRx
Alprolix
Biogen Acquires Rights to Eisai’s Alzheimer’s Drugs
Bloomberg
Wed, 03/5/14 - 08:58 am
Biogen Idec
Alzheimer's disease
Eisai
Drugmakers Actavis, Biogen, Valeant Hold Near Highs
Investors.com
Tue, 03/4/14 - 10:17 pm
Valeant Pharmaceuticals
Actavis
Biogen Idec
Biogen Idec Keeps Momentum Going With MS Drug Tecfidera
Investors.com
Mon, 03/3/14 - 03:34 pm
Tecfidera
MS
multiple sclerosis
Biogen Idec
One Reason the Biotech Boom Won’t Turn to Bust
Barron's
Tue, 02/25/14 - 11:17 am
biotech
Biogen Idec
Regeneron
Biotech: Too Big for Its Britches?
Barron's
Mon, 02/24/14 - 05:05 pm
biotech
Celgene
Gilead Sciences
Biogen Idec
Amgen
Regeneron
Here's Why You Should Look Beyond NICE's Pushback on Tecfidera
Motley Fool
Mon, 02/24/14 - 05:01 pm
Tecfidera
NICE
MS
multiple sclerosis
Biogen Idec
Isis shares jump on promising spinal disorder treatment data
Yahoo/Reuters
Fri, 02/21/14 - 05:01 pm
Isis Pharmaceuticals
ISIS-SMN
antisense
Biogen Idec
Bayer cites success in hemophilia study, but may still trail Biogen Idec
Fierce Biotech
Tue, 02/18/14 - 10:33 am
Bayer
Biogen Idec
hemophilia
BAY94-9027
Factor VIII
Biogen Idec Chairman: New Boss Same as the Old Boss?
Yahoo/24-7 Wall St
Mon, 02/17/14 - 10:16 am
Biogen Idec
Stelios Papadopoulos
Biogen Names Papadopoulos as Its Chairman, Replacing Young
Bloomberg
Mon, 02/17/14 - 09:14 am
Biogen Idec
Stelios Papadopoulos
The Zacks Analyst Blog Highlights: Gilead, Cytokinetics, Puma, Biogen and Spectrum Pharmaceuticals
Yahoo/Zacks.com
Thu, 02/13/14 - 09:18 am
Gilead Sciences
Cytokinetics
Puma Biotechnology
Biogen Idec
Spectrum Pharmaceuticals

Pages